Sheau Wen Lok-Publications

Sheau Wen Lok-Publications

Researcher: 

Selected publications

  1. Lee M, Lok SW, Turner NH, Day D, Greenberg S, Green M, Foo S, Yip D, Nott LM, Gibbs P, De Boer R. A real-world registry to evaluate Her2-directed therapy in Australian patients with metastatic breast cancer. DOI: 10.1200/JCO.2017.35.15 _suppl.e12515 J Clin Oncol 35, no. 15_suppl.
  2. Lindeman GJ, Lok SW, Bergin AR, Whittle JR, Shackleton K, Sherman P, Dawson SJ, Desai J, Liew D, Mann B, Murugasu A, Roberts AW, Rosenthal M, Visvader J. Safety and efficacy of the BCL2 inhibitor venetoclax in estrogen receptor (ER) and BCL2-positive metastatic breast cancer: The mBEP study. J Clin Oncol 35, no. 15_suppl (May 2017) 1044-1044.
  3. Nolan E, Vaillant F, Branstetter D, Pal B, Giner G, Whitehead L, Lok SW, Mann GB, kConFab, Rohrbach K, Huang LY, Soriano R, Smyth GK, Dougall WC, Visvader JE, Lindeman GJ. RANK Ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. Nat Med 2016; 22: 933-939. PMID: 27322743
  4. Lok SW, Merino D, Visvader JE, Lindeman GL. Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer. Oncogene 2015; 35(15): 1877-1887. PMID: 26257067